A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)

BACKGROUND: The clinical and economic burden of community-acquired bacterial pneumonia (CABP) is significant and is anticipated to increase as the population ages and pathogens become more resistant. Delafloxacin is a fluoroquinolone antibiotic approved in the United States for the treatment of adul...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: Horcajada, Juan P, Salata, Robert A, Álvarez-Sala, Rodolfo, Nitu, Floarea Mimi, Lawrence, Laura, Quintas, Megan, Cheng, Chun-Yen, Cammarata, Sue
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Major Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6975251/
https://ncbi.nlm.nih.gov/pubmed/31988972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz514
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares